Barcelona identified as Europe’s second-best hub for biotech investment

More and more international biotech startups and companies are setting their sights on Barcelona and its metropolitan area to develop their activity. In fact, the Catalan capital is the second-best European location for investment in the biotech sector, according to the CPHI Annual Report, published on the occasion of CPHI Barcelona, the world’s leading pharmaceutical fair, which will take place from 24 to 26 October at Fira de Barcelona’s Gran Via venue. The report also places Spain as the sixth country in the world and the third European with the greatest ‘pharma growth potential’ by 2024.

CPHI’s annual report is based on a macro-survey of pharmaceutical company executives around the world and its results are widely seen as the key metrics for global pharma prospects in the year ahead. On this occasion, the report highlights Barcelona as the second-best European location for biotech investment, behind only the greater London region and well ahead of the major Swiss hubs, Berlin, or Paris. In this ranking (CPHI European Biotech Index), the most productive investment opportunities for biotech companies and start-ups are analysed.

In fact, global executives advised that Barcelona need only ‘build further manufacturing resources’ and/or offer some ‘potential inbound investment opportunities’ (tax breaks or investment programmes) to see a sizable shift in prospects. Significantly, 53% of executives envisage implementing these measures will make Catalonia a more attractive alternative to the UK and Switzerland as a home for the European HQ of US pharma companies.

Spain increases its pharma growth potential

On the other hand, the CPHI report highlights Spain’s strong rise in the ranking of ‘growth potential’ for 2024 among the leading pharmaceutical economies.Thus, Spain achieves its best score (6.6) in the history of the ranking with an increase of 17.8% compared to last year, rising 7 places in the ranking and reaching sixth place in the world behind India, the United States, China, Germany, and Switzerland. At the European level, Spain is in third place, surpassing the scores of countries such as the United Kingdom (6.3), Italy (6) and France (5.9)) and is practically at the same level as Switzerland (6.7). Spain also stands out in the sector’s global competitiveness index, with an improvement of 12.1%, the highest of all the countries analysed.

“It’s very fitting that in a year, when our event will welcome over 40,000 executives to Barcelona, Spain has powered ahead in our eponymous pharma rankings – including taking second place in the European Biotech Index*. These rapid increases point to excellent growth prospects for Spain in 2024 and for Barcelona to continue its rise as a globally significant biotech and biosciences hub,” commented Sherma Ellis-Daal, Brand Director at CPHI Barcelona.

The largest pharmaceutical trade fair returns to Barcelona

CPHI Barcelona, the world’s leading event for the pharmaceutical industry, will take place at Fira de Barcelona’s Gran Via venue from 24-26 October. Organised by Informa Markets, CPHI Barcelona will bring together more than 1,800 exhibitors and attendees from 171 countries, representing the entire pharmaceutical supply chain, including ingredient manufacturers, finished dose and generic providers, global pharma innovators, supply chain logistics providers and machinery.

“One of the reasons we chose to bring CPHI to Barcelona again is the strength of the region, its world-class manufacturing and emerging biotechs. Crucially, this is further supported by our report findings, which has delivered a massive vote of confidence for the city and its pharma prosects in 2024.The event is a true melting pot of ideas, companies, and technologies. It’s what makes CPHI so special and at the heart of driving growth, not only in Catalonia or Spain this year, but in the pharma industry globally” added Sherma Ellis-Daal.

For further information on CPHI Barcelona or its report, please visit:

For media enquiries, please contact:

Alex Heeley or Nidhi Narain
De Facto Communications
T: +44 (0) 203 735 8165 / +44 (0) 7769015043
Email: /

About CPHI
CPHI is the leading global community for pharmaceutical professionals, hosting a portfolio of digital and in-person connection opportunities across the whole pharma supply chain on a scale like no other. Held annually, the CPHI world fair is itinerant in Europe and is replicated with local editions in China, India, Japan, Korea, the United States, the Middle East, and Southeast Asia.

At the heart of Pharma
CPHI South East Asia (12-14 Jul 2023 at QSNCC, Bangkok, Thailand); CPHI Barcelona (24-26 October 2023 at Fira Barcelona, Barcelona), CPHI & PMEC India (28-30 November 2023 at the India Expo Mart, Greater Noida, Delhi NCR – Delhi, India); Pharmapack Europe (24-25 Jan, 2024 at Paris Expo, Porte de Versailles – Hall 7.2, Paris). CPHI Japan (17-19 April, 2024 at the Big Sight Exhibition Centre – Tokyo, Japan); CPHI North America (7-9 May, 2024 at Pennsylvania Convention Center, United States); CPHI China (19-21 June 2024 at SNIEC – Shanghai, China); CPHI South East Asia (12-14 Jul 2023 at QSNCC, Bangkok, Thailand); With support from year-round pharma news, products and services at CPHI Online.

About Informa Markets
Informa Markets creates platforms for industries and specialist markets to trade, innovate and grow. Our portfolio is comprised of more than 550 international B2B events and brands in markets including Healthcare & Pharmaceuticals, Infrastructure, Construction & Real Estate, Fashion & Apparel, Hospitality, Food & Beverage, and Health & Nutrition, among others. We provide customers and partners around the globe with opportunities to engage, experience and do business through face-to-face exhibitions, specialist digital content and actionable data solutions. As the world’s leading exhibitions organizer, we bring a diverse range of specialist markets to life, unlocking opportunities and helping them to thrive 365 days of the year.

For more information, please visit